GROUP ONE TRADING, L.P. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C959. A total of 4 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,237,500
+236.5%
11,000
+182.1%
0.00%
+300.0%
Q2 2023$367,770
-84.0%
3,900
-82.8%
0.00%
-87.5%
Q1 2023$2,297,694
-16.1%
22,700
-12.0%
0.01%
+60.0%
Q3 2022$2,740,000
-26.4%
25,800
-32.5%
0.01%
-16.7%
Q2 2022$3,724,000
-60.5%
38,200
-62.0%
0.01%
-33.3%
Q1 2022$9,422,000
+368.8%
100,500
+325.8%
0.01%
+350.0%
Q4 2021$2,010,000
+302.8%
23,600
+353.8%
0.00%
+100.0%
Q3 2021$499,000
-76.5%
5,200
-76.1%
0.00%
-66.7%
Q2 2021$2,122,000
+251.9%
21,800
+251.6%
0.00%
+200.0%
Q1 2021$603,000
-83.3%
6,200
-83.6%
0.00%
-83.3%
Q4 2020$3,614,000
+322.2%
37,700
+323.6%
0.01%
+100.0%
Q3 2020$856,000
-19.3%
8,900
+2.3%
0.00%
-40.0%
Q2 2020$1,061,000
+21.4%
8,700
-13.9%
0.01%
-28.6%
Q1 2020$874,000
-84.1%
10,100
-80.2%
0.01%
-81.1%
Q4 2019$5,493,000
+231.3%
51,100
+177.7%
0.04%
+184.6%
Q3 2019$1,658,000
+172.7%
18,400
+155.6%
0.01%
+116.7%
Q2 2019$608,000
+138.4%
7,200
+148.3%
0.01%
+100.0%
Q1 2019$255,000
-45.9%
2,900
-56.1%
0.00%
-25.0%
Q4 2018$471,000
+27.6%
6,600
+120.0%
0.00%
+33.3%
Q3 2018$369,000
-87.0%
3,000
-89.6%
0.00%
-87.5%
Q2 2018$2,829,000
+34.3%
28,800
+13.4%
0.02%
+14.3%
Q1 2018$2,106,000
-48.8%
25,400
-52.1%
0.02%
-27.6%
Q4 2017$4,112,000
+4681.4%
53,000
+3685.7%
0.03%
+2800.0%
Q3 2017$86,000
-77.2%
1,400
-82.9%
0.00%
-75.0%
Q2 2017$377,000
-17.1%
8,200
-21.9%
0.00%
-20.0%
Q1 2017$455,000
-79.1%
10,500
-81.3%
0.01%
-76.2%
Q4 2016$2,179,000
+25.1%
56,300
+63.7%
0.02%
+10.5%
Q3 2016$1,742,000
+10.5%
34,400
-0.9%
0.02%0.0%
Q2 2016$1,577,000
+27.0%
34,700
+10.5%
0.02%
+5.6%
Q1 2016$1,242,000
-63.8%
31,400
-48.2%
0.02%
-56.1%
Q4 2015$3,428,000
-6.0%
60,600
-33.8%
0.04%
-18.0%
Q3 2015$3,645,000
+56.1%
91,600
+87.3%
0.05%
+51.5%
Q2 2015$2,335,000
-33.7%
48,900
-44.9%
0.03%
-40.0%
Q1 2015$3,522,000
+22.3%
88,700
-31.2%
0.06%
+27.9%
Q4 2014$2,880,000
+198.8%
128,900
+109.6%
0.04%
+186.7%
Q3 2014$964,000
+36.2%
61,500
+28.9%
0.02%
+36.4%
Q2 2014$708,000
+248.8%
47,700
+278.6%
0.01%
+266.7%
Q1 2014$203,000
+13.4%
12,600
-34.4%
0.00%0.0%
Q4 2013$179,000
-86.1%
19,200
-83.1%
0.00%
-88.0%
Q3 2013$1,285,000
+182.4%
113,500
+233.8%
0.02%
+127.3%
Q2 2013$455,00034,0000.01%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 185,700$18,102,0000.01%
GROUP ONE TRADING, L.P. 38,200$3,724,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 1,400$136,0000.00%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders